Results 31 to 40 of about 10,338 (183)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?

open access: yesРациональная фармакотерапия в кардиологии, 2016
Relationship of metoprolol clinical efficacy with its different salts (tartrate, succinate, fumarate) as well as its presentations (tablets with immediate, controlled or sustained release) is analyzed.
E. V. Kuleshova
doaj   +1 more source

Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study

open access: yesClinical and Translational Science, 2022
Large, observational genetic studies are commonly used to identify genetic factors associated with diseases and disease‐related traits. Such cohorts have not been commonly used to identify genetic predictors of drug dosing or concentrations, perhaps ...
Maxime Meloche   +9 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Análisis de costo efectividad del uso de metoprolol succinato en el tratamiento de la hipertensión arterial y la falla cardiaca en Colombia

open access: yesRevista Colombiana de Cardiología, 2012
realizar una evaluación de costo-efectividad del uso de metoprolol succinato frente a metoprolol tartrato y carvedilol en el tratamiento de pacientes con insuficiencia cardiaca congestiva e hipertensión arterial en Colombia, desde la perspectiva del ...
Martín Romero, MD., MSc.   +1 more
doaj   +1 more source

Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males

open access: yesClinical and Translational Science, 2023
Females present a higher risk of adverse drug reactions. Sex‐related differences in drug concentrations may contribute to these observations but they remain understudied given the underrepresentation of females in clinical trials.
Jessica Hindi   +13 more
doaj   +1 more source

Effects of Orotic Acid-Induced Non-Alcoholic Fatty Liver on the Pharmacokinetics of Metoprolol and its Metabolites in Rats

open access: yesJournal of Pharmacy & Pharmaceutical Sciences, 2019
Purpose: Preliminary study results have shown that rats with non-alcoholic fatty liver disease (NAFLD) induced by 1% orotic acid-containing diet have decreased hepatic CYP2D activity.
Won Seok Bang   +4 more
doaj   +1 more source

Neutrophil stunning by metoprolol reduces infarct size [PDF]

open access: yes, 2017
The β1-adrenergic-receptor (ADRB1) antagonist metoprolol reduces infarct size in acute myocardial infarction (AMI) patients. The prevailing view has been that metoprolol acts mainly on cardiomyocytes.
Garcia-Prieto, Jaime   +46 more
core   +1 more source

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension

open access: yesThe Scientific World Journal, 2013
Objectives. We planned to compare the impact of two beta blockers, metoprolol and nebivolol, on arterial blood pressure during exercise in patients with mild hypertension. Methods.
Huseyin Ugur Yazici   +3 more
doaj   +1 more source

Use of beta-blockers for the treatment of cardiovascular diseases: focus on metoprolol

open access: yesМедицинский совет, 2015
The article tells about the mechanisms of action of beta-blockers. Pharmacokinetic, pharmacodynamic and interaction properties of metoprolol are discussed.
O. D. Ostroumova, V. M. Fomina
doaj   +1 more source

Poly(vinyl alcohol)-based membranes for metoprolol transdermal delivery

open access: yes, 2021
In this work controlled release devices for transdermal administration of metoprolol were developed. Poly(vinyl alcohol) and poly(vinyl pyrrolidone) were used for producing membranes by solvent- casting technique.
SA Aljlil   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy